Physician profile
Vinu S Abraham
NPI 1336123249
$13,048.11
in general payments reported to CMS, 2019-2025
23 companies · $1,368 in 2025
The $1,368 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,559 · 2020: $2,222 · 2021: $336 · 2022: $395 · 2023: $118 · 2024: $51.13 · 2025: $1,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $963 · Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $962.72 |
| Food and Beverage | $574.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,638.30 | 2019-2020 | |
| Atricure, INC. | $3,237.19 | 2019-2025 | Synergy Ablation System |
| Edwards Lifesciences Corporation | $3,107.00 | 2019-2023 | |
| Livanova USA, INC. | $1,585.30 | 2019 | |
| Clearflow INC. | $478.35 | 2019 | |
| Abiomed | $321.89 | 2019-2025 | |
| Boston Scientific Corporation | $118.71 | 2020 | |
| Abbott Laboratories | $91.01 | 2022 | |
| Kls-Martin L.P. | $77.54 | 2019-2022 | |
| Davol INC. | $76.20 | 2019 | |
| Ethicon US, LLC | $50.54 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.01 | 2019-2021 | |
| Chiesi USA, INC. | $27.57 | 2021-2025 | Kengreal, Cleviprex |
| Medtronic, INC. | $27.44 | 2021 | |
| Kci USA, INC. | $24.48 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $23.37 | 2023 | Enhertu |
| Solventum Corporation | $20.48 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Novo Nordisk INC | $20.45 | 2025 | Wegovy |
| Mallinckrodt Enterprises LLC | $19.15 | 2019 | |
| Eisai INC. | $18.46 | 2024 | |
| Stryker Corporation | $18.34 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $17.58 | 2022 | |
| Angiodynamics, INC. | $16.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinu Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.